Moving towards molecular-guided treatments: erlotinib and clinical outcomes in non-small-cell lung cancer patients
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2011 ◽
Vol 81
(2)
◽
pp. S585
Keyword(s):
2011 ◽
Vol 29
(15_suppl)
◽
pp. 7566-7566
◽
Keyword(s):
Keyword(s):